<DOC>
	<DOCNO>NCT01997372</DOCNO>
	<brief_summary>Severe acquire aplastic anaemia ( SAA ) life-threatening disease characterize pancytopenia hypoplastic bone marrow . Immunosuppressive treatment antithymocyte globulin ( ATG ) cyclosporine remain standard regimen response rate 70 % excellent overall survival . However , clinical trial illustrate response complete remission rate different dos ATG.And data report child SAA far .</brief_summary>
	<brief_title>Different Doses Anti-thymocyte Globin Treat Child Severe Aplastic Anemia</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<criteria>clinical diagnosis childhood acquire severe aplastic anemia ( SAA ) clinical diagnosis childhood acquire severe aplastic anemia ( SAA )</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>ATG</keyword>
	<keyword>SAA</keyword>
	<keyword>immunosuppressive treatment</keyword>
	<keyword>cyclosporine</keyword>
</DOC>